Company Filing History:
Years Active: 2023
Title: Innovations of Chanjuan Qu in Autoimmune Myocarditis Research.
Introduction
Chanjuan Qu is a notable inventor based in Beijing, China. He has made significant contributions to the field of autoimmune myocarditis through his innovative research and patenting efforts. His work focuses on developing a mouse model that accurately simulates the pathogenesis of autoimmune myocarditis.
Latest Patents
Chanjuan Qu holds a patent for a preparation method of an anti-PD-1/PD-L1 monoclonal antibody (mAb)-induced autoimmune myocarditis model. This patent describes a method that involves mediating a model with adeno-associated virus 9 (AAV9) to achieve high expression of PDL1 in myocardial tissue. The application of an anti-PD-1/PD-L1 mAb to this model allows for a realistic simulation of the disease, closely resembling the pathophysiological status of clinical patients. The model boasts a high modeling rate and enables dynamic monitoring of the condition.
Career Highlights
Chanjuan Qu is affiliated with Peking Union Medical College Hospital, where he conducts his research. His work has garnered attention for its potential to improve understanding and treatment of autoimmune myocarditis.
Collaborations
Chanjuan Qu collaborates with esteemed colleagues, including Yining Wang and Jian Wang, to further advance research in this critical area of medicine.
Conclusion
Chanjuan Qu's innovative contributions to the field of autoimmune myocarditis through his patented research model highlight the importance of scientific advancements in understanding complex diseases. His work continues to pave the way for future research and potential therapeutic developments.